NCT07059845
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07059845
Title A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer (FLORENZA)
Acronym FLORENZA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
St. George Private Hospital /ID# 276570 RECRUITING Kogarah New South Wales 2217 Australia Details
Icon Cancer Centre Wesley /ID# 277199 RECRUITING Auchenflower Queensland 4066 Australia Details
Burnside War Memorial Hospital /ID# 277602 RECRUITING Adelaide South Australia 5065 Australia Details
Icon Cancer Centre Hobart /ID# 277688 RECRUITING Hobart Tasmania 7000 Australia Details
Monash Health - Monash Medical Centre /ID# 276984 RECRUITING Clayton Victoria 3168 Australia Details
Austin Hospital /ID# 276534 RECRUITING Melbourne Victoria 3084 Australia Details
Seoul National University Hospital /ID# 276182 RECRUITING Seoul Seoul Teugbyeolsi 03080 South Korea Details
Yonsei University Health System Severance Hospital /ID# 276266 RECRUITING Seoul Seoul Teugbyeolsi 03722 South Korea Details
Samsung Medical Center /ID# 276261 RECRUITING Seoul Seoul Teugbyeolsi 06351 South Korea Details
Korea University Guro Hospital /ID# 276194 RECRUITING Seoul Seoul Teugbyeolsi 08308 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field